Cytokine activation is predictive of mortality in Zambian patients with AIDS-related diarrhoea

[1]  H. Ullum,et al.  Reduced mortality and CD4 cell loss among carriers of the interleukin-10 −1082G allele in a Zimbabwean cohort of HIV-1-infected adults , 2007, AIDS.

[2]  M. Lederman,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Nature Medicine.

[3]  M. Gatt,et al.  Review article: bacterial translocation in the critically ill – evidence and methods of prevention , 2006, Alimentary pharmacology & therapeutics.

[4]  B. Chi,et al.  Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. , 2006, JAMA.

[5]  S. Tschoeke,et al.  PLASMA CYTOKINE MEASUREMENTS AUGMENT PROGNOSTIC SCORES AS INDICATORS OF OUTCOME IN PATIENTS WITH SEVERE SEPSIS , 2005, Shock.

[6]  M. Farthing,et al.  Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized‐controlled trial , 2005, Alimentary pharmacology & therapeutics.

[7]  K. Mönkemüller,et al.  Occurrence of Gastrointestinal Opportunistic Disorders in AIDS Despite the Use of Highly Active Antiretroviral Therapy , 2005, Digestive Diseases and Sciences.

[8]  J. Mwansa,et al.  Responses of small intestinal architecture and function over time to environmental factors in a tropical population. , 2004, The American journal of tropical medicine and hygiene.

[9]  C. Cohen,et al.  Mortality and burden of disease in a cohort of HIV-seropositive adults in Nairobi, Kenya , 2004, International journal of STD & AIDS.

[10]  N. Pantazis,et al.  Elevated serum levels of soluble immune activation markers are associated with increased risk for death in HAART-naive HIV-1-infected patients. , 2003, AIDS patient care and STDs.

[11]  Zambia,et al.  Zambia Demographic and Health Survey 2001-2002 , 2003 .

[12]  H. Makita,et al.  Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[13]  M. Farthing,et al.  Albendazole chemotherapy for AIDS‐related diarrhoea in Zambia—clinical, parasitological and mucosal responses , 2002, Alimentary pharmacology & therapeutics.

[14]  M. Leal,et al.  Usefulness of Route of Transmission, Absolute CD8+ T-Cell Counts, and Levels of Serum Tumor Necrosis Factor Alpha as Predictors of Survival of HIV-1-Infected Patients with Very Low CD4+ T-Cell Counts , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[15]  R. Bucala,et al.  Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.

[16]  W. Ollier,et al.  Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression , 1997, AIDS.

[17]  D. Fuchs,et al.  Systemic immune activation as a potential determinant of wasting in Zambians with HIV-related diarrhoea. , 1996, QJM : monthly journal of the Association of Physicians.

[18]  J. Romand.  Bacterial translocation in the critically ill , 1996 .

[19]  M. Molyneux,et al.  Bacteraemia and mortality among adult medical admissions in Malawi--predominance of non-typhi salmonellae and Streptococcus pneumoniae. , 2001, The Journal of infection.

[20]  W. Lynn.  Anti-endotoxin therapeutic options for the treatment of sepsis. , 1998, The Journal of antimicrobial chemotherapy.

[21]  R. Atkins,et al.  Migration inhibitory factor expression in experimentally induced endotoxemia. , 1997, The American journal of pathology.

[22]  J. Ntozi,et al.  AIDS mortality in Uganda: circumstances, factors and impact of death. , 1997, Health transition review : the cultural, social, and behavioural determinants of health.

[23]  A. Mowat,et al.  Analysis of enteropathy induced by tumour necrosis factor alpha. , 1993, Cytokine.